PRNP and colorectal carcinoma: In this study, we synthesized an oligonucleotide with an aptamer (Apt) sequence to target PrPC, which was then used to fabricate the PrPC-targeted Dox DDS (PrPC-Apt-functionalized doxorubicin-oligomer-AuNPs (PrPC-Apt DOA)) for CRC treatment.